...
首页> 外文期刊>Journal of thrombosis and thrombolysis >The beneficial effects of postconditioning on no-reflow phenomenon after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction
【24h】

The beneficial effects of postconditioning on no-reflow phenomenon after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction

机译:后处理对ST段抬高急性心肌梗死经皮冠状动脉介入治疗后无复流现象的有益作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

No-reflow phenomenon is a serious complication of percutaneous coronary intervention (PCI) which is closely related to the incidence of major adverse cardiovascular events. It has been demonstrated that Postconditioning (PostC) during primary PCI confers protection against ischemia-reperfusion injury and thus might reduce infarct size. However, whether PostC may exert its beneficial effects on acute myocardial infarction (AMI) patients by reducing no-reflow phenomenon is still unknown. Sixty two patients diagnosed with ST-elevation AMI were randomly assigned to study group (n = 32) or control group (n = 30). Blood samples were obtained and assayed for creatine kinase MB (CK-MB) and high-sensitive C-reactive protein (hs-CRP). Determinants of reflow, including final thrombolysis in myocardial infarction (TIMI) grade-3 flow, ST-segment resolution (STR), myocardial blush grades-3 (MBG-3) and corrected thrombolysis in myocardial infarction frame count (cTFC), were comparative between the two groups. Compared with control group, more patients in study group were identified as the final TIMI grade-3 flow (81.3 vs. 56.7 %, P = 0.036), MBG-3 (23 vs. 14 %, P = 0.043) and STR ≥50 % (93.8 vs. 73.3 %, P = 0.029), while patients in study group had less cTFC (28.5 ± 9.1 vs. 37.4 ± 12.4, P = 0.002) After PCI, study group was associated with lower levels of CK-MB (2,397.6 ± 470.2 vs. 2,159.9 ± 485.5, P = 0.028), Troponin-I (197.5 ± 32.5 vs. 154 ± 43.1, P = 0.041) and hs-CRP (5.5 ± 4.5 vs. 9.5 ± 5.2 mg/L, P = 0.019) in comparison with control group. Left ventricle ejection fraction was better in the study group than in the control group (55.1 ± 9.8 vs. 42.9 ± 10.7, P = 0.042). PostC could improve myocardial reperfusion in patients with ST-elevation AMI undergoing PCI by reducing no-reflow. However, due to the limited sample size, the results of our study should not be considered conclusive.
机译:无复流现象是经皮冠状动脉介入治疗(PCI)的严重并发症,与主要不良心血管事件的发生率密切相关。已经证明,在原发性PCI中进行后处理(PostC)可以防止缺血再灌注损伤,因此可以减小梗塞面积。但是,PostC是否可以通过减少无再流现象来对急性心肌梗死(AMI)患者发挥有益作用尚不清楚。将62例诊断为ST抬高AMI的患者随机分配至研究组(n = 32)或对照组(n = 30)。获得血样并测定肌酸激酶MB(CK-MB)和高敏C反应蛋白(hs-CRP)。比较回流的决定因素,包括心肌梗死(TIMI)3级血流的最终溶栓,ST段分辨率(STR),心肌腮红3级(MBG-3)和心肌梗死框架计数(cTFC)的校正溶栓两组之间。与对照组相比,研究组中更多的患者被确定为最终TIMI 3级血流(81.3 vs. 56.7%,P = 0.036),MBG-3(23 vs. 14%,P = 0.043)和STR≥50 %(93.8 vs. 73.3%,P = 0.029),而研究组患者的cTFC较少(28.5±9.1 vs. 37.4±12.4,P = 0.002)PCI后,研究组患者的CK-MB水平较低( 2,397.6±470.2与2,159.9±485.5,P = 0.028),肌钙蛋白I(197.5±32.5与154±43.1,P = 0.041)和hs-CRP(5.5±4.5与9.5±5.2 mg / L,P = 0.019)与对照组相比。研究组的左心室射血分数比对照组好(55.1±9.8比42.9±10.7,P = 0.042)。 PostC可以通过减少无复流来改善接受PCI的ST抬高的AMI患者的心肌再灌注。但是,由于样本量有限,我们的研究结果不应被认为是结论性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号